Galera Therapeutics Inc.(GTRX:NSD) 6 Bearish signals detected

STA Research
by: STA Research

Galera Therapeutics Inc Stock Analysis:

Based on the Galera Therapeutics Inc stock forecasts from 5 analysts, the average analyst target price for Galera Therapeutics Inc is USD 23.20 over the next 12 months. Galera Therapeutics Inc’s average analyst rating is Sell. Stock Target Advisor’s own stock analysis of Galera Therapeutics Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Galera Therapeutics Inc’s stock price was USD 1.27Galera Therapeutics Inc’s stock price has changed by +7.63% over the past week, +0.00% over the past month and -87.08% over the last year.

What we like:

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What we don’t like:

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative earnings

The company had negative total earnings in the most recent four quarters.

Disclaimer

Stock Target Advisor is not a broker/dealer, investment advisor, or platform for making stock buying or selling decisions. Our goal is to democratize and simplify financial information through automated analysis, aggregation of stock information, and education to help investors with their research. No content on our site, blogs or newsletters constitutes – or should be understood as constituting – a recommendation to enter into any securities transactions or to engage in any of the investment strategies presented in our site content. We also cannot guarantee the accuracy of any information presented on our site and in our analysis.

Leave a Reply

Your email address will not be published.